Federal Register / Vol. 83, No. 12 / Thursday, January 18, 2018 / Notices 2671 

205–2737. Copies of non-confidential 

documents filed in connection with this 

investigation are or will be available for 

inspection during official business 

hours (8:45 a.m. to 5:15 p.m.) in the 

Office of the Secretary, U.S. 

International Trade Commission, 500 E 

Street SW, Washington, DC 20436, 

telephone (202) 205–2000. General 

information concerning the Commission 

may also be obtained by accessing its 

internet server at https://www.usitc.gov. 

The public record for this investigation 

may be viewed on the Commission’s 

electronic docket (EDIS) at https://

edis.usitc.gov. Hearing-impaired 

persons are advised that information on 

this matter can be obtained by 

contacting the Commission’s TDD 

terminal on (202) 205–1810. 

SUPPLEMENTARY INFORMATION: The 

Commission instituted this investigation 

on October 25, 2016, based on a 

complaint filed by Andrea Electronics 

Corp. of Bohemia, New York 

(‘‘Andrea’’). 81 FR 73418 (Oct. 25, 

2016). The complaint alleges violations 

of section 337 by reason of infringement 

of certain claims of U.S. Patent No. 

6,049,607 (‘‘the ’607 patent’’), U.S. 

Patent No. 6,363,345 (‘‘the ’345 patent’’), 

and U.S. Patent No. 6,377,637 (‘‘the ’637 

patent’’). The Commission’s notice of 

investigation named the following 

respondents: Apple Inc. of Cupertino, 

California (‘‘Apple’’); and Samsung 

Electronics Co., Ltd. of Gyeonggi-do, 

Republic of Korea, and Samsung 

Electronics America, Inc. of Ridgefield 

Park, New Jersey (collectively, 

‘‘Samsung’’). The Office of Unfair 

Import Investigations (‘‘OUII’’) is also a 

party in this investigation. Samsung was 

previously terminated from the 

investigation. All asserted claims of the 

’607 and ’637 patents were also 

previously terminated from the 

investigation. 

On October 26, 2017, the ALJ issued 

her final ID finding no violation of 

section 337 by Apple for the ’345 patent. 

Specifically, the final ID found that 

Andrea does not have standing to assert 

the ’345 patent, the accused products do 

not infringe the ’345 patent, and Andrea 

has not met the domestic industry 

requirements. 

On November 8, 2017, Andrea and 

OUII each filed timely petitions for 

review of the final ID. That same day, 

Apple filed a contingent petition for 

review of the final ID. On November 16, 

2017, the parties each filed a timely 

response to the petitions for review. On 

November 27, 2017, the private parties 

filed their public interest comments 

pursuant to Commission Rule 210.50. 

No public interest comments were 

received from the public. 

Having examined the record of this 

investigation, including the ALJ’s final 

ID, the petitions for review, and the 

responses thereto, the Commission has 

determined to review-in-part the final 

ID. Specifically, the Commission has 

determined to review the ID’s findings 

on (1) standing, (2) infringement, (3) 

invalidity, (4) inequitable conduct, and 

(5) domestic industry. 

The parties are invited to brief their 

responses to the following question 

only, with reference to the applicable 

law and the evidentiary record. 

1. Is a determination on whether a licensee 

is subject to an exclusive license necessary to 

reach the ‘‘all substantial rights’’ analysis? 

Are the factors set forth in Azure Networks, 

LLC v. CSR PLC, 771 F.3d 1336 (Fed. Cir. 

2014), judgment vacated on other grounds, 

CSR PLC et.al. v. Azure Networks, 135 S. Ct. 

1846, 2015 W1 582818 (Apr. 20, 2015), 

relevant to the question of standing raised in 

this investigation? 

The parties are not to brief other 

issues on review, which are adequately 

presented in the parties’ existing filings. 

At this time, the Commission is not 

requesting written submissions on 

remedy, public interest, or bonding. 

Written Submissions: Each party’s 

written submission responding to the 

above questions and any response to the 

initial submissions should be no more 

than 20 pages. The written submissions 

must be filed no later than close of 

business on Wednesday, January 24, 

2018. Reply submissions must be filed 

no later than the close of business on 

Wednesday, January 31, 2018. No 

further submissions on these issues will 

be permitted unless otherwise ordered 

by the Commission. 

Persons filing written submissions 

must file the original document 

electronically on or before the deadlines 

stated above and submit 8 true paper 

copies to the Office of the Secretary by 

noon the next day pursuant to 

Commission Rule 210.4(f), 19 CFR 

210.4(f). Submissions should refer to the 

investigation number (‘‘Inv. No. 1026’’) 

in a prominent place on the cover page 

and/or the first page. (See Handbook for 

Electronic Filing Procedures,https://

www.usitc.gov/secretary/documents/ 

handbook_on_filing_procedures.pdf). 

Persons with questions regarding filing 

should contact the Secretary, (202) 205– 

2000. 

Any person desiring to submit a 

document to the Commission in 

confidence must request confidential 

treatment. All such requests should be 

directed to the Secretary to the 

Commission and must include a full 

statement of the reasons why the 

Commission should grant such 

treatment. See 19 CFR 201.6. Documents 

for which confidential treatment by the 

Commission is properly sought will be 

treated accordingly. All information, 

including confidential business 

information and documents for which 

confidential treatment is properly 

sought, submitted to the Commission for 

purposes of this Investigation may be 

disclosed to and used: (i) By the 

Commission, its employees and Offices, 

and contract personnel (a) for 

developing or maintaining the records 

of this or a related proceeding, or (b) in 

internal investigations, audits, reviews, 

and evaluations relating to the 

programs, personnel, and operations of 

the Commission including under 5 

U.S.C. Appendix 3; or (ii) by U.S. 

government employees and contract 

personnel, solely for cybersecurity 

purposes. All contract personnel will 

sign appropriate nondisclosure 

agreements. All non-confidential 

written submissions will be available for 

public inspection at the Office of the 

Secretary and on EDIS. 

The authority for the Commission’s 

determination is contained in section 

337 of the Tariff Act of 1930, as 

amended, 19 U.S.C. 1337, and in Part 

210 of the Commission’s Rules of 

Practice and Procedure, 19 CFR part 

210. 

By order of the Commission. 

Issued: January 11, 2018. 

Lisa R. Barton, 

Secretary to the Commission. 

[FR Doc. 2018–00736 Filed 1–17–18; 8:45 am] 

BILLING CODE P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–392] 

Bulk Manufacturer of Controlled 

Substances Application: Chemtos, 

LLC 

ACTION: Notice of application. 

DATES: Registered bulk manufacturers of 

the affected basic classes, and 

applicants therefore, may file written 

comments on or objections to the 

issuance of the proposed registration on 

or before March 19, 2018. 

ADDRESSES: Written comments should 

be sent to: Drug Enforcement 

Administration, Attention: DEA Federal 

Register Representative/DRW, 8701 

Morrissette Drive, Springfield, Virginia 

22152. 


sradovich on DSK3GMQ082PROD with NOTICES
2672 Federal Register / Vol. 83, No. 12 / Thursday, January 18, 2018 / Notices 

SUPPLEMENTARY INFORMATION: The 

Attorney General has delegated his 

authority under the Controlled 

Substances Act to the Administrator of 

the Drug Enforcement Administration 

(DEA), 28 CFR 0.100(b). Authority to 

exercise all necessary functions with 

respect to the promulgation and 

implementation of 21 CFR part 1301, 

incident to the registration of 

manufacturers, distributors, dispensers, 

importers, and exporters of controlled 

substances (other than final orders in 

connection with suspension, denial, or 

revocation of registration) has been 

redelegated to the Assistant 

Administrator of the DEA Diversion 

Control Division (‘‘Assistant 

Administrator’’) pursuant to section 7 of 

28 CFR part 0, appendix to subpart R. 

In accordance with 21 CFR 

1301.33(a), this is notice that on October 

23, 2017, Chemtos, LLC, 14101 W. 

Highway 290, Building 2000B, Austin, 

Texas 78737–9331 applied to be 

registered as a bulk manufacturer for the 

following basic classes of controlled 

substances: 

Controlled substance Drug code Schedule 

3-Fluoro-N-methylcathinone (3–FMC) ............................................................................................................................. 1233 I 

Cathinone ........................................................................................................................................................................ 1235 I 

Methcathinone ................................................................................................................................................................. 1237 I 

4-Fluoro-N-methylcathinone (4–FMC) ............................................................................................................................. 1238 I 

Pentedrone (a-methylaminovalerophenone) ................................................................................................................... 1246 I 

Mephedrone (4-Methyl-N-methylcathinone) .................................................................................................................... 1248 I 

4-Methyl-N-ethylcathinone (4–MEC) ............................................................................................................................... 1249 I 

Naphyrone ....................................................................................................................................................................... 1258 I 

N-Ethylamphetamine ....................................................................................................................................................... 1475 I 

N,N-Dimethylamphetamine .............................................................................................................................................. 1480 I 

Fenethylline ..................................................................................................................................................................... 1503 I 

Aminorex .......................................................................................................................................................................... 1585 I 

4-Methylaminorex (cis isomer) ........................................................................................................................................ 1590 I 

Gamma Hydroxybutyric Acid ........................................................................................................................................... 2010 I 

Methaqualone .................................................................................................................................................................. 2565 I 

Mecloqualone .................................................................................................................................................................. 2572 I 

JWH–250 (1-Pentyl-3-(2-methoxyphenylacetyl) indole) .................................................................................................. 6250 I 

SR–18 (Also known as RCS–8) (1-Cyclohexylethyl-3-(2-methoxyphenylacetyl) indole) ................................................ 7008 I 

ADB–FUBINACA (N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide) ............. 7010 I 

5-Fluoro-UR–144 and XLR11 [1-(5-Fluoro-pentyl)1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone ................ 7011 I 

AB–FUBINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide) ..................... 7012 I 

JWH–019 (1-Hexyl-3-(1-naphthoyl)indole) ...................................................................................................................... 7019 I 

MDMB–FUBINACA (Methyl 2-(1-(4-fluorobenzyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate) ...................... 7020 I 

AB–PINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide) ......................................... 7023 I 

THJ–2201 [1-(5-fluoropentyl)-1H-indazol-3-yl](naphthalen-1-yl)methanone ................................................................... 7024 I 

AB–CHMINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide ................. 7031 I 

MAB–CHMINACA (N-(1-amino-3,3dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide) ........ 7032 I 

5F–AMB (Methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3-methylbutanoate) .............................................. 7033 I 

5F–ADB; 5F–MDMB–PINACA (Methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate) ...... 7034 I 

ADB–PINACA (N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide) ................................. 7035 I

MDMB–CHMICA, MMB–CHMINACA (Methyl 2-(1-(cyclohexylmethyl)-1H-indole-3-carboxamido)-3,3- 

dimethylbutanoate).

7042 I 

APINACA and AKB48 N-(1-Adamantyl)-1-pentyl-1H-indazole-3-carboxamide .............................................................. 7048 I 

5F–APINACA, 5F–AKB48 (N-(adamantan-1-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide) .................................. 7049 I 

JWH–081 (1-Pentyl-3-(1-(4-methoxynaphthoyl) indole) .................................................................................................. 7081 I 

SR–19 (Also known as RCS–4) (1-Pentyl-3-[(4-methoxy)-benzoyl] indole .................................................................... 7104 I 

JWH–018 (also known as AM678) (1-Pentyl-3-(1-naphthoyl)indole) .............................................................................. 7118 I 

JWH–122 (1-Pentyl-3-(4-methyl-1-naphthoyl) indole) ..................................................................................................... 7122 I 

UR–144 (1-Pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone ................................................................. 7144 I 

JWH–073 (1-Butyl-3-(1-naphthoyl)indole) ....................................................................................................................... 7173 I 

JWH–200 (1-[2-(4-Morpholinyl)ethyl]-3-(1-naphthoyl)indole) .......................................................................................... 7200 I 

AM2201 (1-(5-Fluoropentyl)-3-(1-naphthoyl) indole) ....................................................................................................... 7201 I 

JWH–203 (1-Pentyl-3-(2-chlorophenylacetyl) indole) ...................................................................................................... 7203 I 

PB–22 (Quinolin-8-yl 1-pentyl-1H-indole-3-carboxylate) ................................................................................................. 7222 I 

5F–PB–22 (Quinolin-8-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate) ............................................................................ 7225 I 

Alpha-ethyltryptamine ...................................................................................................................................................... 7249 I 

Ibogaine ........................................................................................................................................................................... 7260 I 

CP–47,497 (5-(1,1-Dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl-phenol) ................................................................ 7297 I 

CP–47,497 C8 Homologue (5-(1,1-Dimethyloctyl)-2-[(1R,3S)3-hydroxycyclohexyl-phenol) .......................................... 7298 I 

Lysergic acid diethylamide .............................................................................................................................................. 7315 I 

2,5-Dimethoxy-4-(n)-propylthiophenethylamine (2C–T–7) .............................................................................................. 7348 I 

Marihuana Extract ........................................................................................................................................................... 7350 I 

Marihuana ........................................................................................................................................................................ 7360 I 

Tetrahydrocannabinols .................................................................................................................................................... 7370 I 

Parahexyl ......................................................................................................................................................................... 7374 I 

Mescaline ......................................................................................................................................................................... 7381 I 

2-(4-Ethylthio-2,5-dimethoxyphenyl) ethanamine (2C–T–2) ........................................................................................... 7385 I 

3,4,5-Trimethoxyamphetamine ........................................................................................................................................ 7390 I 

4-Bromo-2,5-dimethoxyamphetamine ............................................................................................................................. 7391 I 

4-Bromo-2,5-dimethoxyphenethylamine .......................................................................................................................... 7392 I 

4-Methyl-2,5-dimethoxyamphetamine ............................................................................................................................. 7395 I 

2,5-Dimethoxyamphetamine ............................................................................................................................................ 7396 I 


sradovich on DSK3GMQ082PROD with NOTICES
Federal Register / Vol. 83, No. 12 / Thursday, January 18, 2018 / Notices 2673 

Controlled substance Drug code Schedule 

JWH–398 (1-Pentyl-3-(4-chloro-1-naphthoyl) indole) ...................................................................................................... 7398 I 

2,5-Dimethoxy-4-ethylamphetamine ................................................................................................................................ 7399 I 

3,4-Methylenedioxyamphetamine .................................................................................................................................... 7400 I 

5-Methoxy-3,4-methylenedioxyamphetamine .................................................................................................................. 7401 I 

N-Hydroxy-3,4-methylenedioxyamphetamine .................................................................................................................. 7402 I 

3,4-Methylenedioxy-N-ethylamphetamine ....................................................................................................................... 7404 I 

3,4-Methylenedioxymethamphetamine ............................................................................................................................ 7405 I 

4-Methoxyamphetamine .................................................................................................................................................. 7411 I 

5-Methoxy-N-N-dimethyltryptamine ................................................................................................................................. 7431 I 

Alpha-methyltryptamine ................................................................................................................................................... 7432 I 

Bufotenine ........................................................................................................................................................................ 7433 I 

Diethyltryptamine ............................................................................................................................................................. 7434 I 

Dimethyltryptamine .......................................................................................................................................................... 7435 I 

Psilocybin ......................................................................................................................................................................... 7437 I 

Psilocyn ........................................................................................................................................................................... 7438 I 

5-Methoxy-N,N-diisopropyltryptamine ............................................................................................................................. 7439 I 

N-Ethyl-1-phenylcyclohexylamine .................................................................................................................................... 7455 I 

1-(1-Phenylcyclohexyl)pyrrolidine .................................................................................................................................... 7458 I 

1-[1-(2-Thienyl)cyclohexyl]piperidine ............................................................................................................................... 7470 I 

1-[1-(2-Thienyl)cyclohexyl]pyrrolidine .............................................................................................................................. 7473 I 

N-Ethyl-3-piperidyl benzilate ............................................................................................................................................ 7482 I 

N-Methyl-3-piperidyl benzilate ......................................................................................................................................... 7484 I 

N-Benzylpiperazine .......................................................................................................................................................... 7493 I 

4-Methyl-alphapyrrolidinopropiophenone (4-MePPP) ..................................................................................................... 7498 I 

2-(2,5-Dimethoxy-4-methylphenyl) ethanamine (2C–D) .................................................................................................. 7508 I 

2-(2,5-Dimethoxy-4-ethylphenyl) ethanamine (2C–E ) .................................................................................................... 7509 I 

2-(2,5-Dimethoxyphenyl) ethanamine (2C–H) ................................................................................................................. 7517 I 

2-(4-iodo-2,5-dimethoxyphenyl) ethanamine (2C–I) ........................................................................................................ 7518 I 

2-(4-Chiara-2,5-dimethoxyphenyl) ethanamine (2C–C) .................................................................................................. 7519 I 

2-(2,5-Dimethoxy-4-nitro-phenyl) ethanamine (2C–N) .................................................................................................... 7521 I 

2-(2,5-Dimethoxy-4-(n)-propylphenyl) ethanamine (2C–P) ............................................................................................. 7524 I 

2-(4-Isopropylthio)-2,5-dimethoxyphenyl) ethanamine (2C–T–4) .................................................................................... 7532 I 

MDPV (3,4-Methylenedioxypyrovalerone) ....................................................................................................................... 7535 I 

2-(4-bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine (25B–NBOMe) .................................................... 7536 I 

2-(4-chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine (25C–NBOMe) .................................................... 7537 I 

2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine (25I–NBOMe) ......................................................... 7538 I 

Methylone (3,4-Methylenedioxy-N-methylcathinone) ...................................................................................................... 7540 I 

Butylone ........................................................................................................................................................................... 7541 I 

Pentylone ......................................................................................................................................................................... 7542 I 

alpha-pyrrolidinopentiophenone (a-PVP) ........................................................................................................................ 7545 I 

alpha-pyrrolidinobutiophenone (a-PBP) .......................................................................................................................... 7546 I 

AM–694 (1-(5-Fluoropentyl)-3-(2-iodobenzoyl) indole) ................................................................................................... 7694 I 

Acetyldihydrocodeine ....................................................................................................................................................... 9051 I 

Benzylmorphine ............................................................................................................................................................... 9052 I 

Codeine-N-oxide .............................................................................................................................................................. 9053 I 

Cyprenorphine ................................................................................................................................................................. 9054 I 

Desomorphine ................................................................................................................................................................. 9055 I 

Etorphine (except HCl) .................................................................................................................................................... 9056 I 

Codeine methylbromide ................................................................................................................................................... 9070 I 

Dihydromorphine ............................................................................................................................................................. 9145 I 

Difenoxin .......................................................................................................................................................................... 9168 I 

Heroin .............................................................................................................................................................................. 9200 I 

Hydromorphinol ............................................................................................................................................................... 9301 I 

Methyldesorphine ............................................................................................................................................................ 9302 I 

Methyldihydromorphine ................................................................................................................................................... 9304 I 

Morphine methylbromide ................................................................................................................................................. 9305 I 

Morphine methylsulfonate ............................................................................................................................................... 9306 I 

Morphine-N-oxide ............................................................................................................................................................ 9307 I 

Myrophine ........................................................................................................................................................................ 9308 I 

Nicocodeine ..................................................................................................................................................................... 9309 I 

Nicomorphine ................................................................................................................................................................... 9312 I 

Normorphine .................................................................................................................................................................... 9313 I 

Pholcodine ....................................................................................................................................................................... 9314 I 

Thebacon ......................................................................................................................................................................... 9315 I 

Acetorphine ...................................................................................................................................................................... 9319 I 

Drotebanol ....................................................................................................................................................................... 9335 I 

U–47700 (3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]-N-methylbenzamide) .............................................................. 9547 I 

AH–7921 (3,4-dichloro-N-[(1-dimethylamino)cyclohexylmethyl]benzamide)) .................................................................. 9551 I 

Acetylmethadol ................................................................................................................................................................ 9601 I 

Allylprodine ...................................................................................................................................................................... 9602 I 

Alphacetylmethadol except levo-alphacetylmethadol ...................................................................................................... 9603 I 

Alphameprodine ............................................................................................................................................................... 9604 I 

Alphamethadol ................................................................................................................................................................. 9605 I 

Benzethidine .................................................................................................................................................................... 9606 I 


sradovich on DSK3GMQ082PROD with NOTICES
2674 Federal Register / Vol. 83, No. 12 / Thursday, January 18, 2018 / Notices 

Controlled substance Drug code Schedule 

Betacetylmethadol ........................................................................................................................................................... 9607 I 

Betameprodine ................................................................................................................................................................ 9608 I 

Betamethadol ................................................................................................................................................................... 9609 I 

Betaprodine ..................................................................................................................................................................... 9611 I 

Clonitazene ...................................................................................................................................................................... 9612 I 

Dextromoramide .............................................................................................................................................................. 9613 I 

Diampromide ................................................................................................................................................................... 9615 I 

Diethylthiambutene .......................................................................................................................................................... 9616 I 

Dimenoxadol .................................................................................................................................................................... 9617 I 

Dimepheptanol ................................................................................................................................................................. 9618 I 

Dimethylthiambutene ....................................................................................................................................................... 9619 I 

Dioxaphetyl butyrate ........................................................................................................................................................ 9621 I 

Dipipanone ....................................................................................................................................................................... 9622 I 

Ethylmethylthiambutene .................................................................................................................................................. 9623 I 

Etonitazene ...................................................................................................................................................................... 9624 I 

Etoxeridine ....................................................................................................................................................................... 9625 I 

Furethidine ....................................................................................................................................................................... 9626 I 

Hydroxypethidine ............................................................................................................................................................. 9627 I 

Ketobemidone .................................................................................................................................................................. 9628 I 

Levomoramide ................................................................................................................................................................. 9629 I 

Levophenacylmorphan .................................................................................................................................................... 9631 I 

Morpheridine .................................................................................................................................................................... 9632 I 

Noracymethadol ............................................................................................................................................................... 9633 I 

Norlevorphanol ................................................................................................................................................................ 9634 I 

Normethadone ................................................................................................................................................................. 9635 I 

Norpipanone .................................................................................................................................................................... 9636 I 

Phenadoxone ................................................................................................................................................................... 9637 I 

Phenampromide .............................................................................................................................................................. 9638 I 

Phenoperidine .................................................................................................................................................................. 9641 I 

Piritramide ........................................................................................................................................................................ 9642 I 

Proheptazine .................................................................................................................................................................... 9643 I 

Properidine ...................................................................................................................................................................... 9644 I 

Racemoramide ................................................................................................................................................................ 9645 I 

Trimeperidine ................................................................................................................................................................... 9646 I 

Phenomorphan ................................................................................................................................................................ 9647 I 

Propiram .......................................................................................................................................................................... 9649 I 

1-Methyl-4-phenyl-4-propionoxypiperidine ...................................................................................................................... 9661 I 

1-(2-Phenylethyl)-4-phenyl-4-acetoxypiperidine .............................................................................................................. 9663 I 

Tilidine ............................................................................................................................................................................. 9750 I 

Acryl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacrylamide) ................................................................................. 9811 I 

Para-Fluorofentanyl ......................................................................................................................................................... 9812 I 

3-Methylfentanyl .............................................................................................................................................................. 9813 I 

Alpha-methylfentanyl ....................................................................................................................................................... 9814 I 

Acetyl-alpha-methylfentanyl ............................................................................................................................................. 9815 I 

Acetyl Fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide) ............................................................................... 9821 I 

Butyryl Fentanyl ............................................................................................................................................................... 9822 I 

4-Fluoroisobutyryl fentanyl (N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide) ......................................... 9824 I 

Beta-hydroxyfentanyl ....................................................................................................................................................... 9830 I 

Beta-hydroxy-3-methylfentanyl ........................................................................................................................................ 9831 I 

Alpha-methylthiofentanyl ................................................................................................................................................. 9832 I 

3-Methylthiofentanyl ......................................................................................................................................................... 9833 I 

Furanyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylfuran-2-carboxamide) ............................................................. 9834 I 

Thiofentanyl ..................................................................................................................................................................... 9835 I 

Beta-hydroxythiofentanyl ................................................................................................................................................. 9836 I 

Amphetamine ................................................................................................................................................................... 1100 II 

Methamphetamine ........................................................................................................................................................... 1105 II 

Lisdexamfetamine ............................................................................................................................................................ 1205 II 

Phenmetrazine ................................................................................................................................................................. 1631 II 

Methylphenidate .............................................................................................................................................................. 1724 II 

Amobarbital ...................................................................................................................................................................... 2125 II 

Pentobarbital .................................................................................................................................................................... 2270 II 

Secobarbital ..................................................................................................................................................................... 2315 II 

Glutethimide ..................................................................................................................................................................... 2550 II 

Nabilone ........................................................................................................................................................................... 7379 II 

1-Phenylcyclohexylamine ................................................................................................................................................ 7460 II 

Phencyclidine ................................................................................................................................................................... 7471 II 

4-Anilino-N-phenethyl-4-piperidine (ANPP) ..................................................................................................................... 8333 II 

Phenylacetone ................................................................................................................................................................. 8501 II 

1-Piperidinocyclohexanecarbonitrile ................................................................................................................................ 8603 II 

Alphaprodine .................................................................................................................................................................... 9010 II 

Anileridine ........................................................................................................................................................................ 9020 II 

Cocaine ............................................................................................................................................................................ 9041 II 

Codeine ........................................................................................................................................................................... 9050 II 

Etorphine HCI .................................................................................................................................................................. 9059 II 


sradovich on DSK3GMQ082PROD with NOTICES
Federal Register / Vol. 83, No. 12 / Thursday, January 18, 2018 / Notices 2675 

Controlled substance Drug code Schedule 

Dihydrocodeine ................................................................................................................................................................ 9120 II 

Oxycodone ....................................................................................................................................................................... 9143 II 

Hydromorphone ............................................................................................................................................................... 9150 II 

Diphenoxylate .................................................................................................................................................................. 9170 II 

Ecgonine .......................................................................................................................................................................... 9180 II 

Ethylmorphine .................................................................................................................................................................. 9190 II 

Hydrocodone ................................................................................................................................................................... 9193 II 

Levomethorphan .............................................................................................................................................................. 9210 II 

Levorphanol ..................................................................................................................................................................... 9220 II 

Isomethadone .................................................................................................................................................................. 9226 II 

Meperidine ....................................................................................................................................................................... 9230 II 

Meperidine intermediate-A .............................................................................................................................................. 9232 II 

Meperidine intermediate-B .............................................................................................................................................. 9233 II 

Meperidine intermediate-C .............................................................................................................................................. 9234 II 

Methadone ....................................................................................................................................................................... 9250 II 

Methadone intermediate .................................................................................................................................................. 9254 II 

Metopon ........................................................................................................................................................................... 9260 II 

Dextropropoxyphene, bulk (non-dosage forms) .............................................................................................................. 9273 II 

Morphine .......................................................................................................................................................................... 9300 II 

Thebaine .......................................................................................................................................................................... 9333 II 

Dihydroetorphine ............................................................................................................................................................. 9334 II 

Levo-alphacetylmethadol ................................................................................................................................................. 9648 II 

Oxymorphone .................................................................................................................................................................. 9652 II 

Noroxymorphone ............................................................................................................................................................. 9668 II 

Phenazocine .................................................................................................................................................................... 9715 II 

Thiafentanil ...................................................................................................................................................................... 9729 II 

Piminodine ....................................................................................................................................................................... 9730 II 

Racemethorphan ............................................................................................................................................................. 9732 II 

Racemorphan .................................................................................................................................................................. 9733 II 

Alfentanil .......................................................................................................................................................................... 9737 II 

Remifentanil ..................................................................................................................................................................... 9739 II 

Sufentanil ......................................................................................................................................................................... 9740 II 

Carfentanil ....................................................................................................................................................................... 9743 II 

Tapentadol ....................................................................................................................................................................... 9780 II 

Bezitramide ...................................................................................................................................................................... 9800 II 

Fentanyl ........................................................................................................................................................................... 9801 II 

Moramide-intermediate .................................................................................................................................................... 9802 II 

The company plans to manufacture 

small quantities of the listed controlled 

substances in bulk for distribution to its 

customers. 

Dated: January 5, 2018. 

Susan A. Gibson, 

Deputy Assistant Administrator. 

[FR Doc. 2018–00710 Filed 1–17–18; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–392] 

Bulk Manufacturer of Controlled 

Substances Application: Alcami 

Wisconsin Corporation 

ACTION: Notice of application. 

DATES: Registered bulk manufacturers of 

the affected basic classes, and 

applicants therefore, may file written 

comments on or objections to the 

issuance of the proposed registration on 

or before March 19, 2018. 

ADDRESSES: Written comments should 

be sent to: Drug Enforcement 

Administration, Attention: DEA Federal 

Register Representative/DRW, 8701 

Morrissette Drive, Springfield, Virginia 

22152. 

SUPPLEMENTARY INFORMATION: The 

Attorney General has delegated his 

authority under the Controlled 

Substances Act to the Administrator of 

the Drug Enforcement Administration 

(DEA), 28 CFR 0.100(b). Authority to 

exercise all necessary functions with 

respect to the promulgation and 

implementation of 21 CFR part 1301, 

incident to the registration of 

manufacturers, distributors, dispensers, 

importers, and exporters of controlled 

substances (other than final orders in 

connection with suspension, denial, or 

revocation of registration) has been 

redelegated to the Assistant 

Administrator of the DEA Diversion 

Control Division (‘‘Assistant 

Administrator’’) pursuant to section 7 of 

28 CFR part 0, appendix to subpart R. 

In accordance with 21 CFR 

1301.33(a), this is notice that on July 4, 

2017, Alcami Wisconsin Corporation, 

W130 N10497 Washington Drive, 

Germantown, Wisconsin 53022 applied 

to be registered as a bulk manufacturer 

of thebaine (9333), a basic class of 

controlled substance listed in schedule 

II. 

The company states they plan to 

conduct clinical trials. 

Dated: January 5, 2018. 

Susan A. Gibson, 

Deputy Assistant Administrator. 

[FR Doc. 2018–00709 Filed 1–17–18; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Notice of Proposed Settlement 

Agreement Under the Oil Pollution Act 

On January 9, 2018, a fully-executed 

proposed Settlement Agreement was 

received by the Department of Justice, 

among the United States on behalf of the 

U.S. Department of the Interior, U.S. 

Fish and Wildlife Service (‘‘FWS’’), the 

State of Georgia, on behalf of the 

Georgia Department of Natural 

Resources (‘‘GDNR’’), and Fukunaga 

Kaiun Co., Ltd., a Japanese company 

that was the former operator of the 

Motor Vessel Fortune Epoch in 

November 2004. 


sradovich on DSK3GMQ082PROD with NOTICES